Literature DB >> 11890454

Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.

Philippe Gasque1, Jim W Neal, Sim K Singhrao, Eamon P McGreal, Yann D Dean, Beek Johan Van, B Paul Morgan.   

Abstract

Complement is an important component of the innate immune response with the capacity to recognize and clear infectious challenges that invade the CNS through a damaged blood brain barrier. For instance, the membrane attack complex is involved in cytotoxic and cytolytic activities while other smaller fragments lead to cell activation (chemotaxis) and phagocytosis of the intruders. It is noteworthy that there is a growing body of evidence that uncontrolled complement biosynthesis and activation in the CNS can contribute to exacerbate the neuronal loss in several neurodegenerative disorders. We provide here an insightful review of the double-edged sword activities of the local innate complement system in the CNS and discuss further the potential therapeutic avenues of delivering complement inhibitors to control brain inflammation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11890454     DOI: 10.1385/mn:25:1:001

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  97 in total

Review 1.  Effects of the membrane attack complex of complement on nucleated cells.

Authors:  B P Morgan
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

2.  Aggregation state-dependent activation of the classical complement pathway by the amyloid beta peptide.

Authors:  S Webster; B Bradt; J Rogers; N Cooper
Journal:  J Neurochem       Date:  1997-07       Impact factor: 5.372

3.  Complement C3 and factor B cerebrospinal fluid concentrations in bacterial and aseptic meningitis.

Authors:  P F Stahel; D Nadal; H W Pfister; P M Paradisis; S R Barnum
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

4.  Neurons express proteins of the classical complement pathway in Alzheimer disease.

Authors:  K Terai; D G Walker; E G McGeer; P L McGeer
Journal:  Brain Res       Date:  1997-09-26       Impact factor: 3.252

5.  Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes.

Authors:  P Gasque; P Chan; M Fontaine; A Ischenko; M Lamacz; O Götze; B P Morgan
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

6.  Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.

Authors:  P Vanguri; C L Koski; B Silverman; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  Expression of complement C4 and C9 genes by human astrocytes.

Authors:  D G Walker; S U Kim; P L McGeer
Journal:  Brain Res       Date:  1998-10-26       Impact factor: 3.252

8.  Localization and cell association of C1q in Alzheimer's disease brain.

Authors:  A Afagh; B J Cummings; D H Cribbs; C W Cotman; A J Tenner
Journal:  Exp Neurol       Date:  1996-03       Impact factor: 5.330

9.  The expression of CD59 in normal human nervous tissue.

Authors:  C Vedeler; E Ulvestad; L Bjørge; G Conti; K Williams; S Mørk; R Matre
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

10.  Association of amyloid P component with complement proteins in neurologically diseased brain tissue.

Authors:  H Akiyama; T Yamada; T Kawamata; P L McGeer
Journal:  Brain Res       Date:  1991-05-10       Impact factor: 3.252

View more
  28 in total

1.  Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.

Authors:  Maria I Leite; Margaret Jones; Philipp Ströbel; Alexander Marx; Ralf Gold; Erik Niks; Jan J G M Verschuuren; Sonia Berrih-Aknin; Francesco Scaravilli; Aurea Canelhas; B Paul Morgan; Angela Vincent; Nick Willcox
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

2.  Complement in experimental autoimmune encephalomyelitis revisited: C3 is required for development of maximal disease.

Authors:  Alexander J Szalai; Xianzhen Hu; Jillian E Adams; Scott R Barnum
Journal:  Mol Immunol       Date:  2007-03-13       Impact factor: 4.407

3.  4-Hydroxy-7-oxo-5-heptenoic Acid Lactone Is a Potent Inducer of the Complement Pathway in Human Retinal Pigmented Epithelial Cells.

Authors:  Mikhail Linetsky; Karina S Bondelid; Sofiya Losovskiy; Vadym Gabyak; Mario J Rullo; Thomas I Stiadle; Vasu Munjapara; Priyali Saxena; Duoming Ma; Yu-Shiuan Cheng; Andrew M Howes; Emeka Udeigwe; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2018-07-09       Impact factor: 3.739

4.  Iron-induced necrotic brain cell death in rats with different aerobic capacity.

Authors:  Mingzhe Zheng; Hanjian Du; Wei Ni; Lauren G Koch; Steven L Britton; Richard F Keep; Guohua Xi; Ya Hua
Journal:  Transl Stroke Res       Date:  2015-02-05       Impact factor: 6.829

Review 5.  The role of immune dysfunction in the pathophysiology of autism.

Authors:  Charity Onore; Milo Careaga; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2011-08-28       Impact factor: 7.217

Review 6.  The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.

Authors:  Yosra Bedoui; Jim W Neal; Philippe Gasque
Journal:  J Neuroimmune Pharmacol       Date:  2018-06-16       Impact factor: 4.147

7.  Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders.

Authors:  Gurudutt Pendyala; Howard S Fox
Journal:  Genome Med       Date:  2010-03-30       Impact factor: 11.117

8.  Alterations in the complement cascade in post-traumatic stress disorder.

Authors:  Lilit P Hovhannisyan; Gohar M Mkrtchyan; Samvel H Sukiasian; Anna S Boyajyan
Journal:  Allergy Asthma Clin Immunol       Date:  2010-02-21       Impact factor: 3.406

9.  Cerebrospinal fluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys.

Authors:  Gurudutt Pendyala; Sunia A Trauger; Ewa Kalisiak; Ronald J Ellis; Gary Siuzdak; Howard S Fox
Journal:  J Proteome Res       Date:  2009-05       Impact factor: 4.466

10.  Complement factor H binds to denatured rather than to native pentameric C-reactive protein.

Authors:  Svetlana Hakobyan; Claire L Harris; Carmen W van den Berg; Maria Carmen Fernandez-Alonso; Elena Goicoechea de Jorge; Santiago Rodriguez de Cordoba; German Rivas; Palma Mangione; Mark B Pepys; B Paul Morgan
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.